Single answer

Is Accuray Incorporated (ARAY) a buy or sell?

4starter turns market data into one clear verdict you can act on.

Hold
$0.803
-0.0016 (-0.20%)
Quote updated: 2025-12-30 21:00 UTC
Trend today
-0.20%
Down today
Volume vs avg
Not available
Target gap
646.83%
above current price
Signal updated
Not available
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices
Add to watchlist

Create a free account to save tickers and track your signals.

Log in to turn on watchlist alerts.

What is the conclusion?

Right now our advanced algorithms say:

YES

Do analysts agree?

We compare consensus targets with today's price.

YES

Consensus target for Accuray Incorporated is $6.00, which is $5.20 (646.83%) above the current price today's price.

Low target: $6.00 | High target: $6.00

Company snapshot

A quick overview of the business and its public profile.

Accuray Incorporated designs develops manufactures and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States Canada Latin America Australia New Zealand Europe the Middle East India Africa Japan China and rest of the Asia Pacific region It offers the CyberKnife System a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain including tumors on or near the spine and in the breast kidney liver lung pancreas and prostate The company also provides the TomoTherapy System including the Radixact System which allows for integrated radiation treatment planning delivery and data management enabling clinicians to deliver ultraprecise treatments to approximately 50 patients per day iDMS data management system a fully integrated treatment planning and data management systems and Accuray precision treatment planning system a treatment planning and data management systems In addition it offers postcontract customer support installation training and other professional services The company primarily markets its products directly to customers including hospitals and standalone treatment facilities through its sales organization as well as to customers through sales agents and group purchasing organizations in the United States and to customers directly and through distributors and sales agents internationally Accuray Incorporated was incorporated in 1990 and is headquartered in Madison Wisconsin

Website: https://www.accuray.com

Rates and inflation backdrop

US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.

Inflation sensitivity

Debt ratio: 0.38. Cash flow to debt ratio: 0.02. Net profit margin: -0.35%. Inflation risk score: high (0.75/1).

Dividend history check

We cannot find any recorded dividends paid in our systems.

Trading liquidity

Yes, the average daily trading liquidity for Accuray Incorporated is $1.4M. You should therefore be able to get in and out of your positions relatively fast.

10-year return check

On Accuray Incorporated, 2015-12-31 had a stock price of $6.75. If you invested back then, your return now would be a loss of $5.95 per share or 88.10%.

Why this answer

We combine price momentum, volatility, and trend signals to simplify the decision to one word.

1

Signal engine scans price, trend, and momentum indicators.

2

Targets and sentiment are checked against the live quote.

3

We keep the output simple: buy, sell, or hold.

Analyst consensus

How Wall Street targets compare to today's price.

$6.00
$5.20 (646.83%) above the current price
Range: $6.00 - $6.00

FAQ

Today's 4starter signal is Hold. That means the signal is mixed right now.

Quotes and targets refresh throughout the trading day, with the latest timestamp shown on the page.

It blends momentum, trend, and volatility indicators into a single decision-oriented verdict.